MindMaze Therapeutics named healthtech executive Zach Henderson CEO to boost global growth of its neuroscience and digital therapeutics.

MindMaze Therapeutics has appointed healthtech executive Zach Henderson as its new CEO, aiming to accelerate the company’s global commercial expansion. Henderson brings extensive experience in health technology, positioning the company to scale its innovative neuroscience and digital therapeutics solutions worldwide. The leadership change marks a strategic move to strengthen market reach and execution.